About 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one
4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one (PubChem CID 14404059) has the molecular formula C18H23N7O3
and a molecular weight of 385.43 g/mol. Its IUPAC name is 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one.
Molecular Properties
| Compound Name | 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one |
| PubChem CID | 14404059 |
| Molecular Formula | C18H23N7O3 |
| Molecular Weight | 385.43 g/mol |
| Exact Mass | 385.19 |
| IUPAC Name | 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one |
| SMILES | CN/C(=C\[N+](=O)[O-])NCCCc1nc2ccc(C3=NNC(=O)CC3C)cc2[nH]1 |
| InChI | InChI=1S/C18H23N7O3/c1-11-8-17(26)23-24-18(11)12-5-6-13-14(9-12)22-15(21-13)4-3-7-20-16(19-2)10-25(27)28/h5-6,9-11,19-20H,3-4,7-8H2,1-2H3,(H,21,22)(H,23,26)/b16-10+ |
| InChIKey | ATOPQSNCPFTARJ-MHWRWJLKSA-N |
| XLogP | 1.24 |
| TPSA | 137.34 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 385.43 |
| LogP ≤ 5 | 1.24 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'nitro_group', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one?
The IUPAC name of 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one (CID 14404059) is 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one.
What is the SMILES notation for 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one?
The canonical SMILES for 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one is CN/C(=C\[N+](=O)[O-])NCCCc1nc2ccc(C3=NNC(=O)CC3C)cc2[nH]1.
What is the InChIKey of 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one?
The InChIKey is ATOPQSNCPFTARJ-MHWRWJLKSA-N. The full InChI is InChI=1S/C18H23N7O3/c1-11-8-17(26)23-24-18(11)12-5-6-13-14(9-12)22-15(21-13)4-3-7-20-16(19-2)10-25(27)28/h5-6,9-11,19-20H,3-4,7-8H2,1-2H3,(H,21,22)(H,23,26)/b16-10+.
What are the key properties of 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one?
4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one has a molecular weight of 385.43 g/mol, XLogP of 1.24, 8 rotatable bonds, 4 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methyl-3-[2-[3-[[(E)-1-(methylamino)-2-nitroethenyl]amino]propyl]-3H-benzimidazol-5-yl]-4,5-dihydro-1H-pyridazin-6-one is sourced from PubChem (CID 14404059), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).